http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-2006001971-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4087b50e333ce88716cf2190ee07ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_173cbaee53930ffb17980982bddf55a2
publicationDate 2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SV-2006001971-A
titleOfInvention FORM OF TRANSDERMAL, LIQUID OR SEMISOLID ADMINISTRATION CONTAINING ACTIVE SUBSTANCE SENSITIVE TO LIGHT, STABLE TO ULTRAVIOLETE RAYS REF. P-SV-77.471 / CD
abstract FORMS OF PHARMACEUTICAL SEMISOLID OR LIQUID ADMINISTRATION FOR TRANSDERMAL USE CONTAINING AN ACTIVE SUBSTANCE SENSITIVE TO UV LIGHT AND AT LEAST AN AUXILIARY SUBSTANCE (UV LIGHT ABSORBER) THAT IS PRESENT IN THE FORM OF ADMINISTRATION. THE METHOD OF ADMINISTRATION OF THE INVENTION IS RELATED TO TRANSDERMAL GELS, WHOSE BASE IS FORMED BY WATER, ALCOHOL, AT LEAST A GEL-FORMING POLYMER AND IF NECESSARY, OTHER COMPONENTS, SUCH GELS ARE ALSO DESIGNED A HYDROPAL HYDROPAL GEL. METHOD OF ADMINISTRATION CONTAINING A PHARMACEUTICALLY SENSITIVE ACTIVE SUBSTANCE TO LIGHT, WHICH APPLICATION SYSTEM HAS A HIGH STABILITY AND DOES NOT PRESENT THE KNOWN DISADVANTAGES THAT ARE PRESENTED WHEN APPLICATION FORMS TRANSMITTED WITH THE MINIMUM SEMITIMATE SEMISTRIES. HARMFUL TO THE USER THAT MAY RESULT FROM PROTECTION N UV PROPOSED, AS P. EX. THE ABSORPTION OF LIGHT PROTECTOR BY THE BODY
priorityDate 2003-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 37.